Ignite Creation Date:
2024-05-05 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00742430
Status:
COMPLETED
Last Update Posted:
2012-02-14
First Post:
2008-08-26
Brief Title:
Resistance on Antithrombotic Drugs in Ischemic Heart Disease
Sponsor:
University of Zagreb
Organization:
University of Zagreb
Study Overview
Official Title:
Assessment of Aspirin and Clopidogrel Resistance in Ischemic Heart Disease Using Multiplate Function Analyser and its Correlation With Major Adverse Cardiac Events
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether aspirin and clopidogrel resistance measured with Multiplate function analyser has a good correlation with incidence of major adverse cardiac events in patients with coronary artery disease CAD
Detailed Description:
Our plan is to enroll 180 patients with diagnosed CAD who electively undergo percutaneous coronary intervention PCI Blood samples will be taken just before the procedure and one day after the procedure and analysed on Multiplate function analyser Assessing aspirin and clopidogrel resistance incidence using Multiplate platelet function analyzer we will also try to find resistance correlation with the incidence of major adverse cardiac events in a one year follow up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None